These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 29350899)
1. Cyclam-Modified PEI for Combined VEGF siRNA Silencing and CXCR4 Inhibition To Treat Metastatic Breast Cancer. Zhou Y; Yu F; Zhang F; Chen G; Wang K; Sun M; Li J; Oupický D Biomacromolecules; 2018 Feb; 19(2):392-401. PubMed ID: 29350899 [TBL] [Abstract][Full Text] [Related]
2. Cholesterol Modification Enhances Antimetastatic Activity and siRNA Delivery Efficacy of Poly(ethylenimine)-Based CXCR4 Antagonists. Wu P; Luo X; Wu H; Yu F; Wang K; Sun M; Oupicky D Macromol Biosci; 2018 Nov; 18(11):e1800234. PubMed ID: 30259651 [TBL] [Abstract][Full Text] [Related]
3. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl Ullah A; Chen G; Hussain A; Khan H; Abbas A; Zhou Z; Shafiq M; Ahmad S; Ali U; Usman M; Raza F; Ahmed A; Qiu Z; Zheng M; Liu D Int J Nanomedicine; 2021; 16():4451-4470. PubMed ID: 34234436 [TBL] [Abstract][Full Text] [Related]
4. Captopril-polyethyleneimine conjugate modified gold nanoparticles for co-delivery of drug and gene in anti-angiogenesis breast cancer therapy. Li M; Li Y; Huang X; Lu X J Biomater Sci Polym Ed; 2015; 26(13):813-27. PubMed ID: 26166244 [TBL] [Abstract][Full Text] [Related]
5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA. Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Kim SH; Lee SH; Tian H; Chen X; Park TG J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850 [TBL] [Abstract][Full Text] [Related]
7. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Jiang G; Park K; Kim J; Kim KS; Hahn SK Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144 [TBL] [Abstract][Full Text] [Related]
8. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer. Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577 [TBL] [Abstract][Full Text] [Related]
10. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Park K; Lee MY; Kim KS; Hahn SK Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167 [TBL] [Abstract][Full Text] [Related]
11. Synergistic Suppression of Tumor Angiogenesis by the Co-delivering of Vascular Endothelial Growth Factor Targeted siRNA and Candesartan Mediated by Functionalized Carbon Nanovectors. Ding X; Su Y; Wang C; Zhang F; Chen K; Wang Y; Li M; Wang W ACS Appl Mater Interfaces; 2017 Jul; 9(28):23353-23369. PubMed ID: 28617574 [TBL] [Abstract][Full Text] [Related]
12. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression. Huang HY; Kuo WT; Chou MJ; Huang YY J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641 [TBL] [Abstract][Full Text] [Related]
13. CXCR4 regulates growth of both primary and metastatic breast cancer. Smith MC; Luker KE; Garbow JR; Prior JL; Jackson E; Piwnica-Worms D; Luker GD Cancer Res; 2004 Dec; 64(23):8604-12. PubMed ID: 15574767 [TBL] [Abstract][Full Text] [Related]
14. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis. Ding L; Zhu C; Yu F; Wu P; Chen G; Ullah A; Wang K; Sun M; Li J; Oupický D Nanomedicine; 2018 Aug; 14(6):1765-1776. PubMed ID: 29777878 [TBL] [Abstract][Full Text] [Related]
16. Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo. Chen Y; Li J; Oupický D Bioconjug Chem; 2018 Feb; 29(2):296-305. PubMed ID: 29338191 [TBL] [Abstract][Full Text] [Related]
17. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Hassan S; Buchanan M; Jahan K; Aguilar-Mahecha A; Gaboury L; Muller WJ; Alsawafi Y; Mourskaia AA; Siegel PM; Salvucci O; Basik M Int J Cancer; 2011 Jul; 129(1):225-32. PubMed ID: 20830712 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Shibata MA; Morimoto J; Shibata E; Otsuki Y Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613 [TBL] [Abstract][Full Text] [Related]
19. A Pt(iv)-mediated polymer architecture for facile and stimuli-responsive intracellular gene silencing with chemotherapy. Jung S; Kim J; Pramanick S; Park H; Lee H; Lee J; Kim WJ Biomater Sci; 2018 Nov; 6(12):3345-3355. PubMed ID: 30357140 [TBL] [Abstract][Full Text] [Related]
20. Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line. Wang Q; Diao X; Sun J; Chen Z Cell Biol Int; 2011 Sep; 35(9):897-904. PubMed ID: 21306303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]